Monsanto (MON) Stock Rating Reaffirmed by Deutsche Bank

Deutsche Bank restated their buy rating on shares of Monsanto (NYSE:MON) in a research report released on Tuesday, January 16th.

A number of other analysts have also recently weighed in on MON. Macquarie cut shares of Monsanto from an outperform rating to a neutral rating in a report on Wednesday, October 4th. BMO Capital Markets reissued a buy rating and set a $128.00 target price on shares of Monsanto in a research note on Thursday, October 5th. Barclays reissued an equal weight rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Wells Fargo & Co raised their target price on shares of Monsanto from $107.50 to $118.00 and gave the company a market perform rating in a research note on Tuesday, October 10th. Finally, Royal Bank of Canada reissued a hold rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of $127.30.

Monsanto (NYSE MON) traded down $0.44 during mid-day trading on Tuesday, hitting $118.64. 4,756,913 shares of the company were exchanged, compared to its average volume of 3,530,000. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28. Monsanto has a 1-year low of $106.97 and a 1-year high of $123.15. The firm has a market cap of $52,300.00, a PE ratio of 21.93, a PEG ratio of 1.70 and a beta of 1.01.

Monsanto (NYSE:MON) last released its quarterly earnings data on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. During the same period last year, the business earned $0.21 EPS. The firm’s revenue was up .3% on a year-over-year basis. analysts expect that Monsanto will post 5.76 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be paid a $0.54 dividend. The ex-dividend date is Thursday, April 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.82%. Monsanto’s dividend payout ratio is currently 39.93%.

In other news, EVP Steven Mizell sold 8,100 shares of Monsanto stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.79% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Gradient Investments LLC acquired a new position in shares of Monsanto in the 4th quarter worth approximately $108,000. Bruderman Asset Management LLC acquired a new position in shares of Monsanto in the 2nd quarter worth approximately $116,000. Tower Research Capital LLC TRC grew its stake in shares of Monsanto by 230.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after purchasing an additional 750 shares during the last quarter. Americafirst Capital Management LLC acquired a new position in shares of Monsanto in the 3rd quarter worth approximately $148,000. Finally, Fieldpoint Private Securities LLC grew its stake in shares of Monsanto by 100.6% in the 2nd quarter. Fieldpoint Private Securities LLC now owns 1,575 shares of the basic materials company’s stock worth $186,000 after purchasing an additional 790 shares during the last quarter. 75.62% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Monsanto (MON) Stock Rating Reaffirmed by Deutsche Bank” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://ledgergazette.com/2018/02/12/monsanto-mon-earns-buy-rating-from-deutsche-bank.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply